A detailed history of Latitude Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Latitude Advisors, LLC holds 708 shares of AMGN stock, worth $198,247. This represents 0.15% of its overall portfolio holdings.

Number of Shares
708
Previous 808 12.38%
Holding current value
$198,247
Previous $252,000 9.52%
% of portfolio
0.15%
Previous 0.18%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$309.38 - $337.38 $30,938 - $33,738
-100 Reduced 12.38%
708 $228,000
Q2 2024

Jul 25, 2024

BUY
$262.75 - $319.31 $212,302 - $258,002
808 New
808 $252,000
Q4 2023

Jan 30, 2024

SELL
$255.7 - $288.46 $8,182 - $9,230
-32 Reduced 4.2%
729 $209,000
Q3 2023

Nov 03, 2023

SELL
$218.65 - $271.46 $64,283 - $79,809
-294 Reduced 27.87%
761 $204,000
Q2 2023

Jul 26, 2023

BUY
$214.27 - $253.37 $27,855 - $32,938
130 Added 14.05%
1,055 $234,000
Q1 2023

Apr 27, 2023

BUY
$225.79 - $275.2 $25,062 - $30,547
111 Added 13.64%
925 $223,000
Q4 2022

Jan 27, 2023

SELL
$229.03 - $291.01 $51,989 - $66,059
-227 Reduced 21.81%
814 $0
Q3 2022

Nov 01, 2022

BUY
$224.46 - $253.15 $8,529 - $9,619
38 Added 3.79%
1,041 $235,000
Q2 2022

Jul 28, 2022

SELL
$230.71 - $256.74 $529,248 - $588,961
-2,294 Reduced 69.58%
1,003 $244,000
Q1 2022

Apr 29, 2022

SELL
$219.27 - $242.57 $25,654 - $28,380
-117 Reduced 3.43%
3,297 $797,000
Q4 2021

Jan 18, 2022

BUY
$198.88 - $227.6 $93,075 - $106,516
468 Added 15.89%
3,414 $768,000
Q3 2021

Oct 14, 2021

BUY
$212.27 - $248.7 $333,263 - $390,459
1,570 Added 114.1%
2,946 $626,000
Q2 2021

Jul 20, 2021

BUY
$233.58 - $259.14 $12,613 - $13,993
54 Added 4.08%
1,376 $335,000
Q1 2021

Apr 14, 2021

BUY
$221.91 - $258.6 $78,556 - $91,544
354 Added 36.57%
1,322 $329,000
Q4 2020

Feb 04, 2021

BUY
$216.38 - $257.67 $209,455 - $249,424
968 New
968 $223,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Latitude Advisors, LLC Portfolio

Follow Latitude Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Latitude Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Latitude Advisors, LLC with notifications on news.